Literature DB >> 29451984

Two-Component Ferritin Nanoparticles for Multimerization of Diverse Trimeric Antigens.

Ivelin S Georgiev1, Michael Gordon Joyce1, Rita E Chen1, Kwanyee Leung1, Krisha McKee1, Aliaksandr Druz1, Joseph G Van Galen1, Masaru Kanekiyo1, Yaroslav Tsybovsky2, Eun Sung Yang1, Yongping Yang1, Priyamvada Acharya1, Marie Pancera1, Paul V Thomas1, Timothy Wanninger1, Hadi M Yassine1, Ulrich Baxa2, Nicole A Doria-Rose1, Cheng Cheng1, Barney S Graham1, John R Mascola1, Peter D Kwong1.   

Abstract

Antigen multimerization on a nanoparticle can result in improved neutralizing antibody responses. A platform that has been successfully used for displaying antigens from a number of different viruses is ferritin, a self-assembling protein nanoparticle that allows the attachment of multiple copies (24 monomers or 8 trimers) of a single antigen. Here, we design two-component ferritin variants that allow the attachment of two different antigens on a single particle in a defined ratio and geometric pattern. The two-component ferritin was specifically designed for trimeric antigens, accepting four trimers per particle for each antigen, and was tested with antigens derived from HIV-1 envelope (Env) and influenza hemagglutinin (HA). Particle formation and the presence of native-like antigen conformation were confirmed through negative-stain electron microscopy and antibody-antigen binding analysis. Immunizations in guinea pigs with two-component ferritin particles, displaying diverse Env, HA, or both antigens, elicited neutralizing antibody responses against the respective viruses. The results provide proof-of-principle for the self-assembly of a two-component nanoparticle as a general technology for multimeric presentation of trimeric antigens.

Entities:  

Keywords:  HIV-1; antibody; immunogenicity; influenza; vaccine

Mesh:

Substances:

Year:  2018        PMID: 29451984     DOI: 10.1021/acsinfecdis.7b00192

Source DB:  PubMed          Journal:  ACS Infect Dis        ISSN: 2373-8227            Impact factor:   5.084


  26 in total

Review 1.  Structure-Based Vaccine Antigen Design.

Authors:  Barney S Graham; Morgan S A Gilman; Jason S McLellan
Journal:  Annu Rev Med       Date:  2019-01-27       Impact factor: 13.739

Review 2.  Advancements in protein nanoparticle vaccine platforms to combat infectious disease.

Authors:  Nina Butkovich; Enya Li; Aaron Ramirez; Amanda M Burkhardt; Szu-Wen Wang
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2020-11-08

Review 3.  Protein-based antigen presentation platforms for nanoparticle vaccines.

Authors:  Brian Nguyen; Niraj H Tolia
Journal:  NPJ Vaccines       Date:  2021-05-13       Impact factor: 7.344

4.  Quadrivalent influenza nanoparticle vaccines induce broad protection.

Authors:  Seyhan Boyoglu-Barnum; Daniel Ellis; Rebecca A Gillespie; Geoffrey B Hutchinson; Young-Jun Park; Syed M Moin; Oliver J Acton; Rashmi Ravichandran; Mike Murphy; Deleah Pettie; Nick Matheson; Lauren Carter; Adrian Creanga; Michael J Watson; Sally Kephart; Sila Ataca; John R Vaile; George Ueda; Michelle C Crank; Lance Stewart; Kelly K Lee; Miklos Guttman; David Baker; John R Mascola; David Veesler; Barney S Graham; Neil P King; Masaru Kanekiyo
Journal:  Nature       Date:  2021-03-24       Impact factor: 69.504

5.  SnoopLigase peptide-peptide conjugation enables modular vaccine assembly.

Authors:  Anne-Marie C Andersson; Can M Buldun; David J Pattinson; Simon J Draper; Mark Howarth
Journal:  Sci Rep       Date:  2019-03-15       Impact factor: 4.379

6.  Prime-Boost Immunizations with DNA, Modified Vaccinia Virus Ankara, and Protein-Based Vaccines Elicit Robust HIV-1 Tier 2 Neutralizing Antibodies against the CAP256 Superinfecting Virus.

Authors:  Michiel T van Diepen; Rosamund Chapman; Nicola Douglass; Shireen Galant; Penny L Moore; Emmanuel Margolin; Phindile Ximba; Lynn Morris; Edward P Rybicki; Anna-Lise Williamson
Journal:  J Virol       Date:  2019-04-03       Impact factor: 5.103

7.  Structure and immunogenicity of a stabilized HIV-1 envelope trimer based on a group-M consensus sequence.

Authors:  Kwinten Sliepen; Byung Woo Han; Ilja Bontjer; Petra Mooij; Fernando Garces; Anna-Janina Behrens; Kimmo Rantalainen; Sonu Kumar; Anita Sarkar; Philip J M Brouwer; Yuanzi Hua; Monica Tolazzi; Edith Schermer; Jonathan L Torres; Gabriel Ozorowski; Patricia van der Woude; Alba Torrents de la Peña; Mariëlle J van Breemen; Juan Miguel Camacho-Sánchez; Judith A Burger; Max Medina-Ramírez; Nuria González; Jose Alcami; Celia LaBranche; Gabriella Scarlatti; Marit J van Gils; Max Crispin; David C Montefiori; Andrew B Ward; Gerrit Koopman; John P Moore; Robin J Shattock; Willy M Bogers; Ian A Wilson; Rogier W Sanders
Journal:  Nat Commun       Date:  2019-05-29       Impact factor: 14.919

8.  Structural and functional evaluation of de novo-designed, two-component nanoparticle carriers for HIV Env trimer immunogens.

Authors:  Aleksandar Antanasijevic; George Ueda; Philip J M Brouwer; Jeffrey Copps; Deli Huang; Joel D Allen; Christopher A Cottrell; Anila Yasmeen; Leigh M Sewall; Ilja Bontjer; Thomas J Ketas; Hannah L Turner; Zachary T Berndsen; David C Montefiori; Per Johan Klasse; Max Crispin; David Nemazee; John P Moore; Rogier W Sanders; Neil P King; David Baker; Andrew B Ward
Journal:  PLoS Pathog       Date:  2020-08-11       Impact factor: 6.823

9.  Mapping the immunogenic landscape of near-native HIV-1 envelope trimers in non-human primates.

Authors:  Christopher A Cottrell; Jelle van Schooten; Charles A Bowman; Meng Yuan; David Oyen; Mia Shin; Robert Morpurgo; Patricia van der Woude; Mariëlle van Breemen; Jonathan L Torres; Raj Patel; Justin Gross; Leigh M Sewall; Jeffrey Copps; Gabriel Ozorowski; Bartek Nogal; Devin Sok; Eva G Rakasz; Celia Labranche; Vladimir Vigdorovich; Scott Christley; Diane G Carnathan; D Noah Sather; David Montefiori; Guido Silvestri; Dennis R Burton; John P Moore; Ian A Wilson; Rogier W Sanders; Andrew B Ward; Marit J van Gils
Journal:  PLoS Pathog       Date:  2020-08-31       Impact factor: 6.823

Review 10.  Stabilizing HIV-1 envelope glycoprotein trimers to induce neutralizing antibodies.

Authors:  Alba Torrents de la Peña; Rogier W Sanders
Journal:  Retrovirology       Date:  2018-09-12       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.